SCHEMBL6856708

SCHEMBL6856708

CC(C)(C)[Si](C)(C)OCc1ccc(OCc2ccccc2)c(Sc2ccc(F)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
STAT3 P40763 1/20 0.39
HTT P42858 1/20 0.39
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
SLC6A9 P48067 1/20 0.37
ALDH1A1 P00352 2/20 0.36
PKM P14618 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MRGPRX4 Q96LA9 2/20 0.35
LRRK2 Q5S007 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089786 0.79 MAPT (0.43) MAPTLMNASMN1; SMN2POLBSTAT3
SCHEMBL7089782 0.79 LMNA (0.43) MAPTLMNASMN1; SMN2POLBSTAT3
SCHEMBL22621079 0.79 MEN1 (0.44) LMNAMEN1KMT2AMAPK1NPC1
SCHEMBL6849377 0.78 KEAP1 (0.40) MAPTLMNASMN1; SMN2POLBSTAT3
SCHEMBL6849571 0.76 RAB9A (0.49) MAPTLMNASMN1; SMN2STAT3HTT
SCHEMBL22398473 0.76 EGFR (0.44) MAPTL3MBTL1MAPK1TDP1
SCHEMBL1121430 0.74 IDO1 (0.50) MAPTLMNASMN1; SMN2POLBSTAT3
SCHEMBL22398472 0.73 MAOB (0.43) MAPTSMN1; SMN2STAT3HTTL3MBTL1
SCHEMBL20742092 0.73 L3MBTL1 (0.45) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL1315036 0.71 IDO1 (0.46) MAPTLMNAALDH1A1L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777442-B2 Diphenyl derivatives BAYER AKTIENGESELLSCHAFT (DE) 2004-08-17 US disclosed
EP-1370523-A1 DIPHENYL DERIVATIVES Bayer Aktiengesellschaft (DE) 2003-12-17 EP disclosed
US-20030105078-A1 Diphenyl derivatives BAYER AKTIENGESSELLSCHAFT (DE) 2003-06-05 US disclosed
WO-2002072539-A1 DIPHENYL DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105078-A1 Diphenyl derivatives DPP4, DPP3, DPM1 MAPT 1592/4885LMNA 1567/4885SMN1; SMN2 4662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.